November 2016

Europe Regenerative Medicines Market - Growth, Trends and Forecasts (2016 - 2021)

Purchase Report
Single user license
Team license
Corporate license

The European regenerative medicines market is expected to reach USD 24.2 billion by 2021, from USD 8.6 billion in 2016, growing at a CAGR of 22.96%. Small molecules and biologics show immense potential for the market and are expected to grow at a CAGR of 17.6%. Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines, which are palliative.

Europe Regenerative Medicines Market-Market Dynamics

The report details several factors driving and restraining the market, some of which are listed below.


  • Technological innovations in stem cell therapy and tissue engineering
  • Growing prevalence of bone and joint diseases
  • Growing need for orthopedic surgeries
  • Increase in awareness
  • Advancements in nanotechnology


The market is restrained by regulatory body rules, ethical issues related to regenerative medicines and cost of the treatment.

The market is segmented on the basis of technology into stem cell therapy, biomaterial, and tissue engineering. By type of applications, the market is segmented into bone graft substitutes, osteoarticular diseases, central nervous system, and cardiovascular. Based on geography, the market is segmented into the UK, France, Germany, Italy, and Spain.

Some of the key players in the market are:

  • Athersys Inc.
  • Mesoblast Ltd.
  • Neo Stem Inc.
  • Neuralstem Inc.
  • StemCells Inc.

Key Deliverables in the Study

  • Market analysis for the European regenerative medicines market, with region-specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market.
  • Identification and analysis of the macro and micro factors that affect the European regenerative medicines market.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions in which this industry is growing and to also identify the regions that are still untapped.

Confused about which report to get?

Download a full report to understand our capabilities
Purchase Report
Single user license
Team license
Corporate license
Our Clients Include View All

Looking to Customize Report?